[1]
“Therapy with an implantable cardioverter defibrillator (ICD) in patients with coronary artery disease and dilated cardiomyopathy: benefits and disadvantages”, Swiss Med Wkly, vol. 139, no. 4546, pp. 647–647, Nov. 2009, doi: 10.4414/smw.2009.12668.